Other diagnostic tests were indicated at discharge in 20.9% of patients, including MRI brain (12 patients, 9.6%), EEG (one patients, 0.8%), blood test including thrombophilia set, thyroids hormones, glycaemia (five patients, 4%), and other specialist consultations (eight patients, 6.5%). This evidence concerns the gene TG and thrombophilia.